Community Acquired Pneumonia (CAP) Market Report

Global and Region Community Acquired Pneumonia (CAP) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：157
  • REPORT CODE：GMM977462
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Community Acquired Pneumonia (CAP) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Community Acquired Pneumonia (CAP)market, defines the market attractiveness level of Community Acquired Pneumonia (CAP) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Community Acquired Pneumonia (CAP) industry, describes the types of Community Acquired Pneumonia (CAP) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Community Acquired Pneumonia (CAP) market and the development prospects and opportunities of Community Acquired Pneumonia (CAP) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Community Acquired Pneumonia (CAP) market in Chapter 13.

    By Player:

    • Kyorin Pharmaceutical

    • Nabriva Therapeutics

    • Paratek Pharmaceuticals

    • Astrazeneca

    • Pfizer

    • C10 Pharma

    • Biotest

    • Bioaegis Therapeutics

    • Melinta Therapeutics

    • Merck

    By Type:

    • Chest X-ray/Radiography

    • Sputum Gram Stain and/or Culture

    • Blood Cultures

    By End-User:

    • Hospitals and Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Community Acquired Pneumonia (CAP) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Community Acquired Pneumonia (CAP) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Community Acquired Pneumonia (CAP) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Community Acquired Pneumonia (CAP) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Community Acquired Pneumonia (CAP) Market Analysis and Outlook to 2022

    • 7.1 Global Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.2 United States Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.3 Europe Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.4 China Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.5 Japan Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.6 India Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    • 7.7 South Korea Community Acquired Pneumonia (CAP) Consumption (2017-2022)

    8 Region and Country-wise Community Acquired Pneumonia (CAP) Market Analysis and Outlook to 2028

    • 8.1 Global Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.2 United States Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.3 Europe Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.4 China Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.5 Japan Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.6 India Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    • 8.7 South Korea Community Acquired Pneumonia (CAP) Consumption Forecast (2022-2028)

    9 Global Community Acquired Pneumonia (CAP) Market Outlook by Types and Applications to 2022

    • 9.1 Global Community Acquired Pneumonia (CAP) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chest X-ray/Radiography Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Sputum Gram Stain and/or Culture Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Blood Cultures Consumption and Growth Rate (2017-2022)

    • 9.2 Global Community Acquired Pneumonia (CAP) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Community Acquired Pneumonia (CAP) Market Outlook by Types and Applications to 2028

    • 10.1 Global Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chest X-ray/Radiography Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Sputum Gram Stain and/or Culture Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Blood Cultures Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Community Acquired Pneumonia (CAP) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Community Acquired Pneumonia (CAP) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Community Acquired Pneumonia (CAP) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Community Acquired Pneumonia (CAP) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Community Acquired Pneumonia (CAP) Market Competitive Analysis

    • 14.1 Kyorin Pharmaceutical

      • 14.1.1 Kyorin Pharmaceutical Company Details

      • 14.1.2 Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Product and Service

    • 14.2 Nabriva Therapeutics

      • 14.2.1 Nabriva Therapeutics Company Details

      • 14.2.2 Nabriva Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nabriva Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • 14.3 Paratek Pharmaceuticals

      • 14.3.1 Paratek Pharmaceuticals Company Details

      • 14.3.2 Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Product and Service

    • 14.4 Astrazeneca

      • 14.4.1 Astrazeneca Company Details

      • 14.4.2 Astrazeneca Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Astrazeneca Community Acquired Pneumonia (CAP) Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Community Acquired Pneumonia (CAP) Product and Service

    • 14.6 C10 Pharma

      • 14.6.1 C10 Pharma Company Details

      • 14.6.2 C10 Pharma Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 C10 Pharma Community Acquired Pneumonia (CAP) Product and Service

    • 14.7 Biotest

      • 14.7.1 Biotest Company Details

      • 14.7.2 Biotest Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biotest Community Acquired Pneumonia (CAP) Product and Service

    • 14.8 Bioaegis Therapeutics

      • 14.8.1 Bioaegis Therapeutics Company Details

      • 14.8.2 Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • 14.9 Melinta Therapeutics

      • 14.9.1 Melinta Therapeutics Company Details

      • 14.9.2 Melinta Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Melinta Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Community Acquired Pneumonia (CAP) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Community Acquired Pneumonia (CAP)

    • Figure Community Acquired Pneumonia (CAP) Picture

    • Table Global Community Acquired Pneumonia (CAP) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Community Acquired Pneumonia (CAP) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Community Acquired Pneumonia (CAP) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Community Acquired Pneumonia (CAP) Consumption by Country (2017-2022)

    • Figure United States Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Table Europe Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Figure China Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Figure Japan Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Figure India Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Community Acquired Pneumonia (CAP) Consumption and Growth Rate (2017-2022)

    • Figure Global Community Acquired Pneumonia (CAP) Consumption Forecast by Country (2022-2028)

    • Figure United States Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Community Acquired Pneumonia (CAP) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chest X-ray/Radiography Consumption and Growth Rate (2017-2022)

    • Figure Global Sputum Gram Stain and/or Culture Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cultures Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Chest X-ray/Radiography Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sputum Gram Stain and/or Culture Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cultures Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Community Acquired Pneumonia (CAP) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Community Acquired Pneumonia (CAP) Export by Region (Top 5 Countries) (2017-2028)

    • Table Kyorin Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyorin Pharmaceutical Community Acquired Pneumonia (CAP) Product and Service

    • Table Nabriva Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nabriva Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nabriva Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • Table Paratek Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paratek Pharmaceuticals Community Acquired Pneumonia (CAP) Product and Service

    • Table Astrazeneca (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Community Acquired Pneumonia (CAP) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Community Acquired Pneumonia (CAP) Product and Service

    • Table C10 Pharma (Foundation Year, Company Profile and etc.)

    • Table C10 Pharma Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table C10 Pharma Community Acquired Pneumonia (CAP) Product and Service

    • Table Biotest (Foundation Year, Company Profile and etc.)

    • Table Biotest Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotest Community Acquired Pneumonia (CAP) Product and Service

    • Table Bioaegis Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioaegis Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • Table Melinta Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Melinta Therapeutics Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Melinta Therapeutics Community Acquired Pneumonia (CAP) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Community Acquired Pneumonia (CAP) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Community Acquired Pneumonia (CAP) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US